BRIAN P. MCKEON - 14 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
EVP, CFO and Treasurer
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Issuer symbol
IDXX
Transactions as of
14 Feb 2025
Net transactions value
-$252,938
Form type
4
Filing time
18 Feb 2025, 21:44:17 UTC
Previous filing
07 Aug 2024
Next filing
23 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +252 +0.81% $0.000000 31,209 14 Feb 2025 Direct F1
transaction IDXX Common Stock Options Exercise $0 +303 +0.97% $0.000000 31,512 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +308 +0.98% $0.000000 31,820 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +299 +0.94% $0.000000 32,119 14 Feb 2025 Direct
transaction IDXX Common Stock Tax liability $252,938 -569 -1.8% $444.53 31,550 14 Feb 2025 Direct
holding IDXX Common Stock 18,050 14 Feb 2025 by Estony McKeon Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise $0 -252 -100% $0.000000 0 14 Feb 2025 Common Stock 252 Direct F2
transaction IDXX Restricted Stock Unit Options Exercise $0 -303 -50% $0.000000 303 14 Feb 2025 Common Stock 303 Direct F3
transaction IDXX Restricted Stock Unit Options Exercise $0 -308 -33% $0.000000 615 14 Feb 2025 Common Stock 308 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -299 -25% $0.000000 894 14 Feb 2025 Common Stock 299 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 25 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2023.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2024.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2025.